Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Belimumab for Prevention of Disease Flares in SLE Patients With Low Disease Activity

NCT04515719 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04515719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04515719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Belimumab for Prevention of Disease Flares in SLE Patients With Low Disease Activity
Lead sponsor
RenJi Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 10, 2021
Completion date
April 10, 2022
Enrollment
231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus